Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer

被引:7
|
作者
Tezel, Cagatay [1 ]
Dogruyol, Talha [2 ]
Alpay, Levent [1 ]
Akyil, Mustafa [3 ]
Evman, Serdar [1 ]
Metin, Serda [1 ]
Baysungur, Volkan [1 ]
Yalcinkaya, Irfan [1 ]
机构
[1] Sureyyapasa Pulmonol & Thorac Surg Training & Res, Dept Thorac Surg, Istanbul, Turkey
[2] Manisa State Hosp, Dept Thorac Surg, TR-45020 Manisa, Turkey
[3] Canakkale State Hosp, Dept Thorac Surg, Canakkale, Turkey
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2020年 / 68卷 / 02期
关键词
N1 lymph node; N2 lymph node; surgical treatment; survival rate; CLASSIFICATION; INVOLVEMENT; SURVIVAL; PATTERN; NUMBER; RATIO;
D O I
10.1055/s-0038-1675345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with N1 non-small cell lung cancer represent a heterogeneous population. The aim of this study is to determine the difference of survival rate between subtypes of N1 disease in surgically resected non-small cell lung cancer patients and to compare the survival in these patients with multi-N1 and single N2 (skip metastasis) disease. Methods Patients who underwent anatomical pulmonary resection in our institution between 2007 and 2014 with a pathological diagnosis of N1 and single N2 positive non-small cell lung cancer were included in the study. N1 positive patients were divided into three groups as single hilar; single interlobar, lobar, or segmental; and multiple N1 positive patients. These groups were compared among themselves as well as with incidentally found single N2 patients. Results A total of 1,742 patients who had non-small cell lung cancer underwent anatomical lung resection. The survival was better in single hilar lymph nodes than other subtypes of N1 disease ( p = 0.015). There was no statistically significant difference in terms of survival between the other subtypes of N1 disease ( p = 0.332). The difference in survival for single N2 disease compared with multi-N1 was not statistically significant ( p = 0.054). Also, when we divided the groups as single and multi-N1, there was a significant difference in survival ( p = 0.025). Conclusion Single hilar lymph nodes with direct invasion have better survival rate than other subtypes of N1. Also, patients with multiple N1 positive lymph nodes have similar survival results compared with single N2 patients. Our results should be confirmed with larger series to better explain N1 disease.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 50 条
  • [31] Prognostic Value of Positive Lymph Node Ratio in Non-Small Cell Lung Cancer
    He, J.
    Pan, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1011 - S1012
  • [32] High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer
    Sterlacci, William
    Wolf, Dominik
    Savic, Spasenija
    Hilbe, Wolfgang
    Schmid, Thomas
    Jamnig, Herbert
    Fiegl, Michael
    Tzankov, Alexandar
    HUMAN PATHOLOGY, 2012, 43 (03) : 339 - 349
  • [33] Blood hemoglobin as an independent prognostic factor in surgically resected stages I and II non-small cell lung cancer patients
    Watine, J
    Berteau, P
    ANNALS OF THORACIC SURGERY, 2002, 73 (06): : 2034 - 2035
  • [34] Comment on prognostic value of epidermal growth factor receptor mutation subtypes in surgically resected non-small cell lung cancer
    Kudo, Yujin
    Shimada, Yoshihisa
    Saji, Hisashi
    Ikeda, Norihiko
    JOURNAL OF THORACIC DISEASE, 2017, 9 (05) : E499 - E502
  • [35] Prognostic value of perioperative changes in the prognostic nutritional index in patients with surgically resected non-small cell lung cancer
    Hayasaka, Kazuki
    Notsuda, Hirotsugu
    Onodera, Ken
    Watanabe, Tatsuaki
    Watanabe, Yui
    Suzuki, Takaya
    Hirama, Takashi
    Oishi, Hisashi
    Niikawa, Hiromichi
    Okada, Yoshinori
    SURGERY TODAY, 2024, 54 (09) : 1031 - 1040
  • [36] The value of tumor volume in surgically resected non-small cell lung cancer
    Iwasaki, A
    Shirakusa, T
    Enatsu, S
    Maekawa, S
    Hamada, T
    Hamasaki, M
    THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (02): : 112 - 116
  • [37] Lymph node micrometastasis in non-small cell lung cancer
    Sun, Jiajing
    Wu, Sikai
    Jin, Zixian
    Ren, Sijia
    Cho, William C.
    Zhu, Chengchu
    Shen, Jianfei
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [38] Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer
    Yoichi Ohtaki
    Kimihiro Shimizu
    Kyoichi Kaira
    Toshiteru Nagashima
    Kai Obayashi
    Seshiru Nakazawa
    Seiichi Kakegawa
    Hitoshi Igai
    Mitsuhiro Kamiyoshihara
    Masahiko Nishiyama
    Izumi Takeyoshi
    Surgery Today, 2016, 46 : 1196 - 1208
  • [39] Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer
    Ohtaki, Yoichi
    Shimizu, Kimihiro
    Kaira, Kyoichi
    Nagashima, Toshiteru
    Obayashi, Kai
    Nakazawa, Seshiru
    Kakegawa, Seiichi
    Igai, Hitoshi
    Kamiyoshihara, Mitsuhiro
    Nishiyama, Masahiko
    Takeyoshi, Izumi
    SURGERY TODAY, 2016, 46 (10) : 1196 - 1208
  • [40] ADAM9 and EGFR Correlated With Lymph Node Metastasis Predicts Worse Prognosis in Surgically Resected Non-Small Cell Lung Cancer
    Zhang, Jun
    Chen, Ning
    Qi, Juan
    Zhou, Baosen
    Qiu, Xueshan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S729 - S729